市场调查报告书
商品编码
1439696
医疗美容设备-全球市场考量、竞争格局、市场预测(2030年)Medical Aesthetic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球医疗美容设备市场规模将于2023年达到135.3326亿美元,到2030年将达到258.843亿美元,预计2024-2030年期间复合年增长率为11.46%。 市场扩张主要是由于老年人口的快速增加和各种美容手术的日益普及。 此外,人们对美丽外表的认识不断提高,以及世界各地正在进行的各种美容手术可能会提振市场。 此外,在预测期内(2024-2030 年),人们对不太复杂或非侵入性整容手术的偏好发生变化、人口肥胖率增加以及产品领域的技术进步可能会增加这些设备的可用性。这些是主要因素可望提振市场。
医疗美容仪器市场动态
由于世界人口老化的增加,医疗美容设备市场预计将大幅成长。 这是因为脸部皮肤鬆弛、粗糙、干燥,尤其是眼睛周围、脸颊和下巴周围的皮肤,是随着年龄增长而出现的常见现象。 此外,大量研究表明,整容手术越来越受到 50 岁以上人群的接受。 例如,根据国际美容整形外科学会发布的2019年统计数据,全球51岁至64岁老年人中使用肉毒桿菌毒素进行整容手术的比例约为25.2%;老年人中进行的病例比例约为6%全球%。 因此,老年人口的增加是未来几年全球医美设备的潜在驱动因素。 例如,根据世界卫生组织(WHO)发布的2022年数据,2019年,全球约有10亿人年龄在60岁或以上。 预计到 2030 年人口将增至 14 亿,到 2050 年将增至 21 亿。
此外,各大公司越来越多地开发和推出新的创新产品,积极製造各种美容设备以满足目标人群的需求,预计未来几年医疗美容设备的数量将会增加。这是可能会带来市场成长。 例如,2022 年 7 月 20 日,Sisram Medical Company 旗下的 Alma(全球能量医学美容解决方案领导者)的 Alma Hybrid(TM) 获得 FDA 批准。 Alma Hybrid(TM) 是第一个包含用于皮肤表面重修的烧蚀性 10,600nm (CO2) 雷射和非烧蚀性 1,570nm 雷射的雷射平台。 这个新平台为医生提供了一个全面的解决方案,可以独立利用每一种一流的激光,并结合两种波长来定制治疗模式。
因此,所有上述因素共同促进了研究期间医疗美容设备市场的成长。
然而,这些设备和手术的高成本、与医美手术相关的临床风险和併发症以及各国缺乏报销政策是全球医美设备市场的限制。此外,由于世界各地为遏制感染传播而取消或拒绝择期手术,COVID-19 大流行也抑制了医疗美容设备市场。 例如,世界卫生组织(WHO)2023年发布的脉搏调查发现,三分之二的国家报告暂停了择期手术,随着疫情的持续,影响将不断累积。 此外,根据美国整形外科医师协会2023年发布的数据,2020年鼻整形、隆乳等整容手术总数减少了15%。 然而,随着许多 COVID-19 疫苗在世界各地获得批准和管理,市场预计将在疫情后恢復正常。
本报告研究和分析了全球医疗美容设备市场,提供市场规模和预测、驱动因素和挑战、公司和产品概况等。
Medical Aesthetic Devices Market By Product Type (Energy-Based Aesthetic Devices [ Laser-Based Aesthetic Devices, Radiofrequency (RF)-Based Aesthetic Devices, Light-Based Aesthetic Devices, Others], Non-Energy Based Aesthetic Devices [Botulinum Toxin, Dermal Fillers, Dermabrasion & Microdermabrasion, Implants, Others]), By Application (Skin Resurfacing And Tightening, Body Contouring And Cellulite Reduction, Hair Removal, Facial Aesthetic Procedures, Breast Augmentation, Others), By End-User (Hospitals, Dermatology Clinics, Others), by geography, is anticipated to grow at a significant CAGR till 2030 owing to the increase in the number of aesthetically conscious population across the globe and growing preference for minimally invasive and non-invasive aesthetic procedures
The global medical aesthetic devices market was valued at USD 13,533.26 million in 2023, growing at a CAGR of 11.46% during the forecast period from 2024 to 2030, in order to reach USD 25,808.43 million by 2030. The increase in the market for medical aesthetic devices is predominantly owing to an exponential rise in the aging population and an increase in the adoption of various aesthetic procedures. Additionally, the growing awareness among the population to look aesthetically presentable and also regarding the various cosmetic procedures performed across the globe is likely to boost the market. Also, shifting preferences towards less complex minimally invasive or non-invasive aesthetic procedures, a rise in obesity among the population, and growing technological advancement in the product arena, among others are some of the key factors expected to raise the market for these devices during the forecast period (2024-2030).
Medical Aesthetic Devices Market Dynamics:
The market for medical aesthetic devices is anticipated to witness considerable growth due to the increase in the geriatric population across the globe. This is because loose facial skin, especially around the eyes, cheeks, and jowls, and roughened or dry skin, among others are some of the common phenomena that usually appear when a person ages. Many surveys have also found that cosmetic surgery is becoming more accepted among those over the age of 50 years. For instance, according to the 2019 statistics published by the International Society of Aesthetic Plastic Surgery, approximately 25.2% of botulinum toxin cosmetic procedures were performed among the population aging between 51 and 64 years, globally and around 6% of the same procedure were performed among the people 65 years or older, worldwide in the same year. Thus, the rising old age population becomes a potential driving factor for the global medical aesthetic devices in the forthcoming years. For instance, according to the 2022 data released by the World Health Organization (WHO), in the year 2019, approximately 1 billion people were aged 60 years and older across the globe. The source also projected the number to increase to 1.4 billion by 2030 and 2.1 billion by 2050.
Moreover, the rising efforts by the key players to develop and launch new and innovative products, who are actively manufacturing various aesthetic devices to cater to the target population is likely to the growth of the market for medical aesthetic devices in the upcoming years. For instance, on July 20, 2022, Alma, a Sisram Medical Company and a global leader in the energy-based medical and aesthetic solutions received FDA clearance for its Alma Hybrid(TM), the first laser platform to include an ablative 10,600 nm (CO2) laser and a non-ablative 1570 nm laser for skin resurfacing. This new platform provides physicians a comprehensive solution to utilize each best-in-class laser independently and to customize the treatment pattern by combining both wavelengths.
Thus, all the aforementioned factors collectively contributed to the growth of the medical aesthetic devices market during the study period.
However, the high cost associated with these devices as well as procedures coupled with clinical risks and complications associated with medical aesthetic procedures, and the lack of reimbursement policies in various countries are some of the restraining factors for the global medical aesthetic devices market.
Additionally, the COVID-19 pandemic has slumped the market for medical aesthetic devices due to the canceled or denied elective surgeries across the globe to curb the transmission of the infection. For instance, as per the World Health Organization "pulse survey" published in the year 2023, two-thirds of countries reported disruptions in elective surgeries, with accumulating consequences as the pandemic is prolonged. Also, as per the data provided by the American Society of Plastic Surgeons in the year 2023, there was an overall 15% reduction in the total number of cosmetic surgeries which included, nose reshaping, breast augmentation, and others in the year 2020. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe, the market is projected to regain normalcy during the post-pandemic.
Medical Aesthetic Devices Market Segment Analysis:
Medical Aesthetic Devices Market By Product Type (Energy-Based Aesthetic Devices [ Laser-Based Aesthetic Devices, Radiofrequency (RF)-Based Aesthetic Devices, Light-Based Aesthetic Devices, Others], Non-Energy Based Aesthetic Devices [Botulinum Toxin, Dermal Fillers, Dermabrasion & Microdermabrasion, Implants, Others]), By Application (Skin Resurfacing And Tightening, Body Contouring and Cellulite Reduction, Hair Removal, Facial Aesthetic Procedures, Breast Augmentation, Others), By End-User (Hospitals, Dermatology Clinics, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the application segment of the medical aesthetic devices market, the body contouring and cellulite reduction subsegment is expected to hold a significant market share in the year 2023. The rising prevalence of obesity worldwide is one of the key factors responsible for an increased demand for body contouring and cellulite reduction procedures across the globe will increase the demand for the related devices. For instance, as per the 2019 data released by the World Obesity Federation, an estimated 2.7 billion adults will be overweight, over 1 billion affected by obesity, and 177 million adults severely affected by obesity by 2025.
Furthermore, a rise in the adoption of various aesthetic and cosmetic procedures by the obese population as they are more tend towards reducing weight and look beautiful is likely to raise the demand for the aesthetic devices.
For instance, according to the International Society of Aesthetic Plastic Surgery 2020 data, globally, about 1,525,197 and 560,464 procedures of liposuction and nonsurgical fat reduction, respectively were performed in the same year.
Additionally, giant manufacturers indulging in various business expansion activities in the body contouring and cellulite reduction field are further expected to bolster the segment growth in the forthcoming years. For instance, recently on May 10, 2022, Allergan Aesthetics, an AbbVie company, and Soliton entered into a definitive agreement under which Allergan Aesthetics will acquire Soliton and RESONICTM, its Rapid Acoustic Pulse device, non-invasive treatment for the short-term improvement in the appearance of cellulite. The acquisition of Soliton expands and complements Allergan Aesthetics' Body Contouring treatment portfolio which includes CoolSculpting® Elite.
Hence, the interplay of all the above-mentioned factors is projected to boost the medical aesthetic devices market in the upcoming years.
North America is expected to dominate the overall Medical Aesthetic Devices Market:
Among all the regions, North America is expected to hold a major share in the overall medical aesthetic devices market in the year 2023 and will retain its market position during the forecast period. This is owing to an increase in the number of various cosmetic surgeries. Moreover, the rising burden of breast cancer, trauma injuries, and an increasing prevalence of obesity, among others, along with the presence of key manufacturers, and the presence of well-developed and advanced healthcare systems in the region are some of the other factors contributing to the regional market growth of medical aesthetic devices market.
For instance, as per the data provided by the American Society of Plastic Surgeons in the year 2020, a total of 15.6 million cosmetic procedures were performed in the same year out of which 2.3 million were cosmetic surgical procedures and 13.2 million were cosmetic minimally-invasive procedures.
Also, the International Society of Aesthetic Plastic Surgery 2020 report stated that approximately 404,229 non-surgical cosmetic surgeries were performed in Mexico in the same year with botulinum toxin being the most common procedure comprising 48.0% of the total non-invasive cosmetic procedures.
Furthermore, the rising incidence of breast cancer in the region would also contribute to the growth of the regional breast implant market. For instance, according to the GLOBOCAN observatory data, published in the year 2020, there were an estimated 253, 465 breast cancer cases in the US in the year 2020 which accounted for about 11.1% of the total new cancer cases.
Also, according to various studies, more than 100,000 women in the US undergo mastectomies which could increase the demand for breast implants thereby augmenting the medical aesthetic devices market.
Furthermore, the launch of various medical aesthetic devices in the countries present in the region such as the United States is also anticipated to bolster the market for these devices during the forecast period. For instance, in June 2020, Cynosure launched the Elite iQ(TM) aesthetic workstation for laser hair removal and skin revitalization in the US along with other countries across the globe.
Hence, all the above-stated factors are projected to propel the regional market growth of medical aesthetic devices during the forecast period.
Medical Aesthetic Devices Market Key Players:
Some of the key market players operating in the Medical Aesthetic Devices market include Johnson & Johnson, HansBioMed., AbbVie Inc., Sebbin, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Suneva Medical, Hanson Medical Inc., SurgiSil, Surgiform Technologies LLC, Alma Lasers, Candela Medical., Lumenis., Cutera., Sciton Inc, Merz Pharma GmbH & Co.KGaA, Bausch Health Companies Inc., Venus Concept., TRIA BEAUTY, Cynosure Inc., GALDERMA, and others.
Recent Developmental Activities in the Medical Aesthetic Devices Market:
In May 2022, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions launched its next generation of breast implants, PERLE(TM).
In February 2022, Galderma received the US Food and Drug Administration (FDA) approval for Restylane® Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21.
In November 2020, Lutronic Introduced Intelligent Care in Muscle Stimulation with IntelliSTIM(TM) - a third-generation body sculpting device.
Key Takeaways from the Medical Aesthetic Devices Market Report Study
Target Audience who can be benefited from the Medical Aesthetic Devices Market Report Study
Frequently Asked Questions for the Medical Aesthetic Devices Market:
Medical aesthetic devices are used to treat various impairments associated with an individual's aesthetic appearance such as wrinkles, scar management, skin discoloration, and excessive fat, among others. The aesthetic devices available in the market are used to perform various minimally invasive and non-invasive cosmetic procedures. Some of the non-invasive devices make use of lasers, ultrasonic sound waves, and others.
The global medical aesthetic devices market was valued at USD 13,533.26 million in 2023, growing at a CAGR of 11.46% during the forecast period from 2024 to 2030, in order to reach USD 25,808.43 million by 2030.
The major factors driving the demand for Medical Aesthetic Devices are an exponential rise in the aging population and an increase in the adoption of various aesthetic procedures. Additionally, growing awareness among the worldwide population regarding various cosmetic procedures and to look aesthetically presentable, shifting preferences towards less complex, minimally invasive, or non-invasive aesthetic procedures, rise in obesity among the population, and growing technological advancement in the product arena, among others are some of the factors expected to raise the market for these devices during the forecast period (2024-2030).
Some of the key market players operating in the Medical Aesthetic Devices market include Johnson & Johnson, HansBioMed., AbbVie Inc., Sebbin, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Suneva Medical, Hanson Medical Inc., SurgiSil, Surgiform Technologies LLC, Alma Lasers, Candela Medical., Lumenis., Cutera., Sciton Inc, Merz Pharma GmbH & Co.KGaA, Bausch Health Companies Inc., Venus Concept., TRIA BEAUTY, Cynosure Inc., GALDERMA, and others.
Among all the regions, North America is expected to hold a major share in the overall medical aesthetic devices market in the year 2023 and will retain its market position during the forecast period. This is owing to an increase in the number of various cosmetic surgeries. Moreover, the rising burden of breast cancer, trauma injuries, and an increasing prevalence of obesity, among others, the presence of key manufacturers, and the presence of well-developed and advanced healthcare systems in the region along with an increase in healthcare expenditure are some of the other factors contributing to the regional market growth of medical aesthetic devices market.